, a fast-growing Swiss image processing startup, announced it has raised a seven-digit Pre-Series A round from Swiss private investors as the company launches new B2B product for biotech research.
The 2020 pandemic underlined the need in remote access to the big volumes of high-quality image data. Increasing requests from biotech industrial and research laboratories showed definite market need in JetRaw
, Dotphoton’s lossless raw image compression solution for biotech imagery.
JetRaw enables researches to compress raw image data up to 10 times without compromising image data quality and reduce time and budgets spent on Big Image Data handling. Furthermore, PCO
Imaging, a world-leading scientific camera manufacturer, collaborated with Dotphoton to commercialize JetRaw as an integrated feature in its current software.
JetRaw has been validated by leading biotech research centres and is available for purchase directly from Dotphoton or through resellers starting September 10, 2020. Closed investment round allows Dotphoton to create a dedicated product team to reinforce Jetraw product development and commercialization process.